About the Trial

The CRASH-19 trial will assess the effectiveness and safety of supportive care interventions for patients hospitalised with suspected or confirmed acute COVID-19 infection with a focus on cardiac and pulmonary protection. We will evaluate the effects of aspirin, the angiotensin receptor blocker losartan, and simvastatin compared with standard care.

Read more….

CRASH-19 Numbers

2
Number of Participating Countries
23
Number of Participating Hospitals
0
Number of Patients Randomised

Latest News